Meta-analysis of Efficacy of Topotecan

GlaxoSmithKline1 enrolled

Overview

This meta-analysis was conducted to investigate the efficacy of Topotecan and other treatments for recurrent and stage IVB carcinoma of the cervix

Studies included in the meta-analysis were: GOG-0179, GOG-0204 \& GOG-0169

Study Type

OBSERVATIONAL

Enrollment

Conditions

Cervical Intraepithelial Neoplasia

Interventions

paclitaxelDRUG

paclitacel

cisplatinDRUG

cisplatin monotherapy

topotecanDRUG

topotecan

Eligibility

Sex: FEMALEMin age: 21 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Randomised Clinical Trials or systematic reviews or meta-analyses * Treatment with topotecan or platinum-based single and combination regimens in female patients of any race with cancer of the cervix recurrent after radiotherapy or stage IVB disease Exclusion Criteria: * None

Outcomes

Primary Outcomes

Survival

Time frame: 12 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.